Milford, MA (PRWEB) June 27, 2010
In accordance with the FDA’s Critical Path Initiative, researchers increasingly use relevant human-based samples for developing new drugs and diagnostics. Procuring those samples is one of the toughest challenges researchers face today. SeraCare Life Sciences, a leading expert in human biologicals, offers an extensive library of remnant human patient samples consisting of serum, plasma, urine, cerebrospinal fluid and amniotic fluid, giving researchers access to affordable human-based samples they need for preclinical research.
Through a partnership with a large European reference lab, SeraCare facilitates access by enabling researchers to search inventory by gender, age, sample type and test parameter – over 2,000 test parameters are listed for the 50,000 samples that are processed daily. Hard to find patient samples involving rare tests or specific age groups are now available to meet researchers’ needs. Minimum sample quantities of 1 mL serum or plasma, 10 mL urine, 0.5 mL cerebrospinal fluid and 1 mL amniotic fluid are suitable for making up large test panels. All samples are ethically collected from a diverse European patient population in compliance with HIPAA. Patient identity for all samples is deleted, yet clinical data for most are available upon request.
“This is for those researchers who want to minimize animal studies, or who have previously drawn samples from their lab colleagues, or who have simply been unable to find a clinician with whom they could work to access patient samples,” says Tamara Smith, Senior Product Manager, SeraCare Life Sciences. “Our Global Patient Samples program makes it easy to acquire fully anonymized samples quickly and economically, and it represents an excellent extension to our existing portfolio of characterized disease state materials.” For additional information, call toll free, +1.866.676.1881, visit the webpage at http://www.seracarecatalog.com/GPS.
About SeraCare Life Sciences, Inc.:
SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics. The Company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.